Jo5hua20,
I gave two options. I'm inclined in thinking that number two will occur. If I'm not mistaken, this is the lowest this stock has gone. People will start selling soonish as they'll want their money due to a)holiday season, and b) they've had enough especially with the stock in the sixes.
In terms of a T/O, I think this stock would be better off breaking up all the components and selling them off, rather than a traditional T/O. They'd likely be a bit less of a loss for investors that way, and a higher profit for those who have an incredibly low buy average.
My "almost certainty" comes from having held this p.o.s stock for a few years. Most people here have held it longer than me. So after a while you start to pick up on what a stock does to a degree. I'm only "almost certain" as there is only one certainty in life and that is uncertainty itself. Well and there's death, but I'm young and hoping immortality is around the corner in my lifetime![]()
- Forums
- ASX - By Stock
- PER
- Ann: Receipt of R&D Tax Incentive payment
PER
percheron therapeutics limited
Add to My Watchlist
5.88%
!
0.8¢

Ann: Receipt of R&D Tax Incentive payment, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $8.699M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $2.01K | 251.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4817091 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1969872 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4817091 | 0.008 |
3 | 2142857 | 0.007 |
2 | 1450000 | 0.006 |
2 | 3999997 | 0.005 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1969872 | 4 |
0.010 | 1993383 | 7 |
0.011 | 2542858 | 6 |
0.012 | 2658324 | 5 |
0.013 | 500000 | 2 |
Last trade - 15.47pm 04/07/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online